Quoc Le-Nguyen - Feb 17, 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Technical Operations Officer and Head of Quality
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Quoc Le-Nguyen
Stock symbol
ETNB
Transactions as of
Feb 17, 2022
Transactions value $
$0
Form type
4
Date filed
2/22/2022, 04:11 PM
Previous filing
Apr 13, 2022
Next filing
Sep 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +17.5K +175% $0.00 27.5K Feb 17, 2022 Direct F1
transaction ETNB Common Stock Award $0 +5K +18.18% $0.00 32.5K Feb 17, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Award $0 +70K $0.00 70K Feb 17, 2022 Common Stock 70K $4.44 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") that vest with respect to one-third of the underlying shares on February 17, 2023, with the remaining two-thirds vesting in equal semi-annual installments over the following two years, subject to the Reporting Person's continued service to the Issuer.
F2 Represents RSUs that vest in equal installments on each of August 1, 2022, February 1, 2023 and August 1, 2023.
F3 This option represents a right to purchase a total of 70,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 17, 2023, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.

Remarks:

Chief Technical Operations Officer and Head of Quality